Philips Receives FDA 510(k) Clearance Of CT Imaging Solutions For Lung Cancer Screening To Help Hospitals Of All Sizes Drive Earlier Detection And Improve Patient Care Decisions

Royal Philips (NYSE: PHG; AEX: PHIA) today announced that any hospital or healthcare facility with one of its indicated computed tomography (CT) models can now become a lung cancer screening center.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news